Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Heim

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
Bone Marrow Transplantation|December 21, 2023
Correction: Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with BusulfanClaire Seydoux, Chakradhara Rao Satyanarayana Uppugunduri, Michael Medinger, et al.
Transplantation and Cellular Therapy|November 7, 2022
Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for MalignancySimone Dertschnig, Peter Gergely, Jürgen Finke, et al.
Annals of Hematology|January 14, 2009
Aplastic anemia and concomitant autoimmune diseasesMagnus P Stalder, Alicia Rovó, Jörg Halter, et al.
Annals of Hematology|October 24, 2020
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trialClaire Seydoux, Michael Medinger, Sabine Gerull, et al.
Annals of Hematology|September 19, 2020
Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantationBeatrice Drexler, Felicitas Zurbriggen, Tamara Diesch, et al.
Blood|August 1, 2007
Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantationAndré Tichelli, Christoph Bucher, Alicia Rovó, et al.
Bone Marrow Transplantation|August 16, 2018
Baseline calprotectin fails to predict incidence of acute gastrointestinal graft vs. host disease: a prospective studyNadine Schmidlin, Jakob R Passweg, Jörg P Halter, et al.
Swiss Medical Weekly|May 23, 2015
Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
Blood Advances|August 27, 2021
Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantationStéphane Buhler, Helen Baldomero, Sylvie Ferrari-Lacraz, et al.
Swiss Medical Weekly|April 4, 2019
Updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Bone Marrow Transplantation|December 21, 2023
Correction: Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with BusulfanClaire Seydoux, Chakradhara Rao Satyanarayana Uppugunduri, Michael Medinger, et al.
Transplantation and Cellular Therapy|November 7, 2022
Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for MalignancySimone Dertschnig, Peter Gergely, Jürgen Finke, et al.
Annals of Hematology|January 14, 2009
Aplastic anemia and concomitant autoimmune diseasesMagnus P Stalder, Alicia Rovó, Jörg Halter, et al.
Annals of Hematology|October 24, 2020
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trialClaire Seydoux, Michael Medinger, Sabine Gerull, et al.
Annals of Hematology|September 19, 2020
Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantationBeatrice Drexler, Felicitas Zurbriggen, Tamara Diesch, et al.
Blood|August 1, 2007
Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantationAndré Tichelli, Christoph Bucher, Alicia Rovó, et al.
Bone Marrow Transplantation|August 16, 2018
Baseline calprotectin fails to predict incidence of acute gastrointestinal graft vs. host disease: a prospective studyNadine Schmidlin, Jakob R Passweg, Jörg P Halter, et al.
Swiss Medical Weekly|May 23, 2015
Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
Blood Advances|August 27, 2021
Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantationStéphane Buhler, Helen Baldomero, Sylvie Ferrari-Lacraz, et al.
Swiss Medical Weekly|April 4, 2019
Updated recommendations for diagnosis and treatment of plasma cell myeloma in SwitzerlandPanagiotis Samaras, Mario Bargetzi, Daniel C Betticher, et al.
Pageof 12